Mesut Ayer

Pesg PNH diagnosis, follow-up and treatment guidelines.

Fahri Şahin, Olga Meltem Akay, Mesut Ayer et al. · PubMed · 2016 · 49 citations · Full text

Disease Diagnosis, Urology, Study Group +14

Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec

Ahmet Emre Eşkazan, Sevil Sadri, Dilek Keskin et al. · Clinical Lymphoma Myeloma & Leukemia · 2017 · 25 citations

Hematological Malignancy, Early Molecular Response, Oncology +10

Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data

Elif Birtaş Ateşoğlu, Zafer Gülbaş, Ant Uzay et al. · Hematological Oncology · 2023 · 25 citations · Full text

Cell Therapy, Immunology, Pathology +16

Leukocytoclastic Vasculitis due to Thalidomide in Multiple Myeloma

Mesut Ayer, Reyhan Diz Küçükkaya, Nadir Alpay et al. · Japanese Journal of Clinical Oncology · 2007 · 23 citations

Hematological Malignancy, Rheumatology, Thrombosis +13

Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia: A six-year follow up

Emine Derviş, Mesut Ayer, Saime Gül Barut · European Journal of Dermatology · 2016 · 22 citations

Hematological Malignancy, Imatinib Therapy, Chronic Myeloid Leukemia +12